InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by ONEILL ALISON, Directeur Médical. Director active across 1 company, notably Surface Oncology, Inc.. In total, 3 disclosures have been logged. History available since 1 March 2020. The latest transaction was filed on 1 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
38,000 shares0Common StockSEC:0001209191-22-015963:0
45,000 shares0Common StockSEC:0001209191-22-003395
45,000 shares0Common StockSEC:0001209191-22-003395:0
3 of 3 declarations
About ONEILL ALISON
Alison O'Neill is the Chief Medical Officer at Surface Oncology, Inc. She is responsible for leading the company's medical initiatives and clinical research. Alison plays a vital role in developing innovative treatments and improving patient outcomes. Her medical expertise and leadership are crucial for advancing Surface Oncology's mission.
